109 related articles for article (PubMed ID: 14525869)
1. Medicines committee felt unable to recommend use of pentosan polyphosphate in vCJD.
Gould M
BMJ; 2003 Oct; 327(7418):770. PubMed ID: 14525869
[No Abstract] [Full Text] [Related]
2. Small improvement seen in teenager with vCJD.
Mayor S
BMJ; 2003 Oct; 327(7418):765. PubMed ID: 14525852
[No Abstract] [Full Text] [Related]
3. Second vCJD patient to receive experimental treatment.
Dyer C
BMJ; 2003 Oct; 327(7420):886. PubMed ID: 14563724
[No Abstract] [Full Text] [Related]
4. Experimental treatment may show promise for vCJD.
Pincock S
Lancet; 2003 Oct; 362(9390):1130. PubMed ID: 14558510
[No Abstract] [Full Text] [Related]
5. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
Todd NV; Morrow J; Doh-ura K; Dealler S; O'Hare S; Farling P; Duddy M; Rainov NG
J Infect; 2005 Jun; 50(5):394-6. PubMed ID: 15907546
[TBL] [Abstract][Full Text] [Related]
6. Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.
Newman PK; Todd NV; Scoones D; Mead S; Knight RS; Will RG; Ironside JW
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):921-4. PubMed ID: 24554103
[TBL] [Abstract][Full Text] [Related]
7. Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.
Parry A; Baker I; Stacey R; Wimalaratna S
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):733-4. PubMed ID: 17314188
[TBL] [Abstract][Full Text] [Related]
8. Creutzfeldt-Jakob disease: hopes for therapy.
Pocchiari M; Ladogana A; Graziano S; Puopolo M
Eur J Neurol; 2008 May; 15(5):435-6. PubMed ID: 18394045
[No Abstract] [Full Text] [Related]
9. [Creutzfeldt-Jakob disease].
Tanii H; Takeda M
Ryoikibetsu Shokogun Shirizu; 2003; (40):319-23. PubMed ID: 14626130
[No Abstract] [Full Text] [Related]
10. Less protease-resistant PrP in a patient with sporadic CJD treated with intraventricular pentosan polysulphate.
Terada T; Tsuboi Y; Obi T; Doh-ura K; Murayama S; Kitamoto T; Yamada T; Mizoguchi K
Acta Neurol Scand; 2010 Feb; 121(2):127-30. PubMed ID: 19804470
[TBL] [Abstract][Full Text] [Related]
11. Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease.
Whittle IR; Knight RS; Will RG
Acta Neurochir (Wien); 2006 Jun; 148(6):677-9; discussion 679. PubMed ID: 16598408
[TBL] [Abstract][Full Text] [Related]
12. Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?
Rainov NG; Tsuboi Y; Krolak-Salmon P; Vighetto A; Doh-Ura K
Expert Opin Biol Ther; 2007 May; 7(5):713-26. PubMed ID: 17477808
[TBL] [Abstract][Full Text] [Related]
13. Family finds hospital willing to give experimental CJD treatment.
Dyer O
BMJ; 2003 Jan; 326(7379):8. PubMed ID: 12511437
[No Abstract] [Full Text] [Related]
14. Insights from Therapeutic Studies for PrP Prion Disease.
Teruya K; Doh-Ura K
Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 27836910
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of pharmacological management in Creutzfeldt-Jakob disease: no options so far?
Miranda LHL; Oliveira AFPH; Carvalho DM; Souza GMF; Magalhães JGM; Júnior JAC; Lima PTMBQ; Júnior RMA; Filho SPL; Melo HMA
Arq Neuropsiquiatr; 2022 Aug; 80(8):837-844. PubMed ID: 36252593
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies.
Farquhar C; Dickinson A; Bruce M
Lancet; 1999 Jan; 353(9147):117. PubMed ID: 10023899
[No Abstract] [Full Text] [Related]
17. [Prevention of venous thromboses under plaster casts after leg injury. Comparison of heparin-calcium and pentosan sulfuric polyester].
Normand R; Mathieu JP
Cah Anesthesiol; 1987 Nov; 35(7):559-62. PubMed ID: 2450622
[No Abstract] [Full Text] [Related]
18. [Use of pentosan sulfuric polyester in the prevention of postoperative deep venous thrombosis of the lower limbs].
Morin JP
Agressologie; 1983 Dec; 24(12):597-9. PubMed ID: 6199995
[No Abstract] [Full Text] [Related]
19. [Contribution of pentosan sulfuric polyester in the prevention of complications of percutaneous arterial dilatation].
Pinot JJ
Presse Med; 1989 Jan 7-14; 18(1):32. PubMed ID: 2464823
[No Abstract] [Full Text] [Related]
20. Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease.
Groveman BR; Ferreira NC; Foliaki ST; Walters RO; Winkler CW; Race B; Hughson AG; Zanusso G; Haigh CL
Sci Rep; 2021 Mar; 11(1):5165. PubMed ID: 33727594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
